Professor Usha Menon

Geciteerd door

	Alles	Sinds 2020
Citaties	40683	19488
h-index	90	63
i10-index	344	260

4200

2100

1050

3150

20032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025124 164 239 310 379 389 490 679 862 1101 1402 1567 1847 2369 2615 2824 3074 3740 3798 4159 3496 3768 492

Openbare toegang

Alles bekijken

334 artikelen

7 artikelen

beschikbaar

niet beschikbaar

Op basis van financieringsmachtigingen

Medeauteurs

Ian JacobsPresident & Vice Chancellor, University of New South Wales, Sydney, AustraliaGeverifieerd e-mailadres voor unsw.edu.au
Ranjit ManchandaProfessor of Gynaecological Oncology and Consultant Gynaecological OncologistGeverifieerd e-mailadres voor qmul.ac.uk
Steven SkatesMassachusetts General HospitalGeverifieerd e-mailadres voor mgh.harvard.edu
John F. TimmsUniversity College LondonGeverifieerd e-mailadres voor ucl.ac.uk
Susan RamusUniversity of New South WalesGeverifieerd e-mailadres voor unsw.edu.au
alexey zaikinProfessor, University College LondonGeverifieerd e-mailadres voor ucl.ac.uk
Anne LanceleyProfessor of Women's Cancer CareGeverifieerd e-mailadres voor ucl.ac.uk
a.mcguireProfessor of Health Economics, London School of EconomicsGeverifieerd e-mailadres voor lse.ac.uk
Evans DG*, Evans G*University of ManchesterGeverifieerd e-mailadres voor mft.nhs.uk
Saskia SandersonData Science Lead, UK Mental Health Mission, and Senior Research Fellow, King's College LondonGeverifieerd e-mailadres voor kcl.ac.uk
Robert BastMD Anderson Cancer CenterGeverifieerd e-mailadres voor mdanderson.org
Lesley J. FallowfieldDirector SHORE-C, University of SussexGeverifieerd e-mailadres voor sussex.ac.uk
Stephen PereiraUniversity College LondonGeverifieerd e-mailadres voor ucl.ac.uk
Paul PharoahCedars-Sinai Medical CenterGeverifieerd e-mailadres voor cshs.org
Andrew TeschendorffCAS Key Lab of Computational Biology, Shanghai Institute of Nutrition and Health, ShanghaiGeverifieerd e-mailadres voor sinh.ac.cn
Rainer CramerProfessor of Mass Spectrometry and Bioanalytical SciencesGeverifieerd e-mailadres voor reading.ac.uk
Alexander GammermanProfessor of Computer Science, Royal Holloway University of LondonGeverifieerd e-mailadres voor rhul.ac.uk
Ali TISSDasman Diabetes InstituteGeverifieerd e-mailadres voor dasmaninstitute.org
Nazar N Amso PhD, FRCOG, FHEAEmeritus Professor, Cardiff UniversityGeverifieerd e-mailadres voor cardiff.ac.uk
Peter SasieniProfessor of Cancer Prevention, King's College LondonGeverifieerd e-mailadres voor kcl.ac.uk

Volgen

Professor Usha Menon

MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College

Geverifieerd e-mailadres voor ucl.ac.uk - Homepage

Cancer screening diagnosis risk prediction Biomarkers


Titel Sorteren op citaties Sorteren op jaar Sorteren op titel	Geciteerd door Geciteerd door	Jaar
Rethinking ovarian cancer: recommendations for improving outcomes S Vaughan, JI Coward, RC Bast, A Berchuck, JS Berek, JD Brenton, ... Nature Reviews Cancer 11 (10), 719-725, 2011	1567	2011
Association analysis identifies 65 new breast cancer risk loci K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ... Nature 551 (7678), 92-94, 2017	1508	2017
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ... Nature reviews Cancer 15 (11), 668-679, 2015	1279	2015
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial IJ Jacobs, U Menon, A Ryan, A Gentry-Maharaj, M Burnell, JK Kalsi, ... The Lancet 387 (10022), 945-956, 2016	1253	2016
Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies Collaborative Group on Hormonal Factors in Breast Cancer The lancet oncology 13 (11), 1141-1151, 2012	1242	2012
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies CL Pearce, C Templeman, MA Rossing, A Lee, AM Near, PM Webb, ... The lancet oncology 13 (4), 385-394, 2012	1148	2012
Polygenic risk scores for prediction of breast cancer and breast cancer subtypes N Mavaddat, K Michailidou, J Dennis, M Lush, L Fachal, A Lee, JP Tyrer, ... The American Journal of Human Genetics 104 (1), 21-34, 2019	1071	2019
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK … U Menon, A Gentry-Maharaj, R Hallett, A Ryan, M Burnell, A Sharma, ... The lancet oncology 10 (4), 327-340, 2009	1056	2009
Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer AE Teschendorff, U Menon, A Gentry-Maharaj, SJ Ramus, ... Genome research 20 (4), 440-446, 2010	975	2010
Management of women who test positive for high-risk types of human papillomavirus: the HART study J Cuzick, A Szarewski, H Cubie, G Hulman, H Kitchener, D Luesley, ... The Lancet 362 (9399), 1871-1876, 2003	778	2003
Screening for ovarian cancer: a pilot randomised controlled trial IJ Jacobs, SJ Skates, N MacDonald, U Menon, AN Rosenthal, AP Davies, ... The Lancet 353 (9160), 1207-1210, 1999	744	1999
Progress and challenges in screening for early detection of ovarian cancer IJ Jacobs, U Menon Molecular & Cellular Proteomics 3 (4), 355-366, 2004	695	2004
New tumor markers: CA125 and beyond RC Bast, D Badgwell, Z Lu, R Marquez, D Rosen, J Liu, KA Baggerly, ... International Journal of Gynecologic Cancer 15 (Suppl 3), 2005	690	2005
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013	664	2013
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial U Menon, A Gentry-Maharaj, M Burnell, N Singh, A Ryan, C Karpinskyj, ... The Lancet 397 (10290), 2182-2193, 2021	585	2021
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer SJ Ramus, H Song, E Dicks, JP Tyrer, AN Rosenthal, MP Intermaggio, ... Journal of the National Cancer Institute 107 (11), djv214, 2015	533	2015
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study W Sieh, M Köbel, TA Longacre, DD Bowtell, A DeFazio, MT Goodman, ... The lancet oncology 14 (9), 853-862, 2013	488	2013
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ... Nature genetics 49 (5), 680-691, 2017	461	2017
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan, EL Goode, K Lawrenson, ... Nature genetics 45 (4), 362-370, 2013	431	2013
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population H Song, E Dicks, SJ Ramus, JP Tyrer, MP Intermaggio, J Hayward, ... Journal of Clinical Oncology 33 (26), 2901-2907, 2015	419	2015

Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.

Artikelen 1–20

Citaties per jaar

Dubbele citaties

Samengevoegde citaties

Medeauteurs toevoegenMedeauteurs

Volgen

Geciteerd door

Medeauteurs